The Brazil strain of Trypanosoma cruzi was shown in vitro to be sensitive to the carbamylating agent NaNCO in a dose and time-dependent fashion. The organisms may be irreversibly inhibited by high doses of NaNCO. It was not found to be effective in vivo in acutely infected mice.
|Original language||English (US)|
|Number of pages||3|
|Journal||Transactions of the Royal Society of Tropical Medicine and Hygiene|
|State||Published - Jan 1 1981|
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Infectious Diseases